Metabolic Disorders Combined with Noninvasive Tests to Screen Advanced Fibrosis in Nonalcoholic Fatty Liver Disease.

Yi-Wen ShiFang-Ping HeJin-Jun ChenHong DengJun-Ping ShiCai-Yan ZhaoYu-Qiang MiZheng-Sheng ZouYong-Jian ZhouFu-Sheng DiRui-Dan ZhengQin DuJia ShangRui-Xu YangBranko PopovicBi-Hui Zhong Jian-Gao Fan

Published in: Journal of clinical and translational hepatology (2021)

Metabolic disorders should be taken into consideration in the diagnosis of advanced fibrosis. With further validation and investigation, new algorithms could be recommended in primary care units to spare patients from unnecessary referral and liver biopsies.

Keyphrases

primary care
end stage renal disease
ejection fraction
newly diagnosed
machine learning
prognostic factors
liver fibrosis
high throughput
single cell
patient reported outcomes